Erythromycin Ethyl Succinate Tablets
Action and use
Macrolide antibacterial.
Definition
Erythromycin Ethyl Succinate Tablets contain Erythromycin Ethyl Succinate.
Identification
Tests
Related substances
Carry out the method for thin-layer chromatography, Appendix III A, using the following solutions.
1 volume of a 15% w/v solution of ammonium acetate, previously adjusted to pH 7.0, 15 volumes of ethanol (96%) and 85 volumes of chloroform as the mobile phase.
The test is not valid unless the chromatogram obtained with solution (4) shows two clearly separated spots.
Any secondary spot in the chromatogram obtained with solution (1) is not more intense than the spot in the chromatogram obtained with solution (5) (5%).
Assay
Weigh and powder 20 tablets. To a quantity of the powdered tablets containing the equivalent of 0.25 g of erythromycin add 200 mL of methanol, shake for 1 hour and dilute to 500 mL with methanol. Dilute 10 mL to 100 mL with phosphate buffer pH 8.0, stand at room temperature for 16 hours and carry out the microbiological assay of antibiotics for erythromycin, Appendix XIV A. The precision of the assay is such that the fiducial limits of error are not less than 95% and not more than 105% of the estimated potency.
Calculate the content of erythromycin in the tablets taking each 1000 IU found to be equivalent to 1 mg of erythromycin. The upper fiducial limit of error is not less than 97.0% and the lower fiducial limit of error is not more than 110.0% of the stated content.
Storage
Erythromycin Ethyl Succinate Tablets should be protected from light.
Labelling
The quantity of active ingredient is stated in terms of the equivalent amount of erythromycin.